Company profile: Abbott
1.1 - Company Overview
Company description
- Provider of pharmaceuticals and healthcare products, including the FreeStyle Libre continuous glucose monitoring system for diabetes management, the MUAC z-score tape for assessing child nutritional status, and COVID-19 antibody testing to detect past infection.
Products and services
- FreeStyle Libre: Abbott engineers a continuous glucose monitoring system delivering real-time glucose readings and continuous updates for diabetes management
- Antibody Testing: Abbott offers a COVID-19-specific test determining if an individual developed antibodies against COVID-19, indicating past infection
- MUAC z-score tape: Abbott produces a pediatric device used to assess nutritional status in children by measuring mid-upper arm circumference for nutritional assessment
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Abbott
InnoPharma
HQ: United States
Website
- Description: Provider of niche-generic, specialty pharmaceutical and bio-pharmaceutical product development, operating as a privately held pharmaceutical R&D company founded in 2005 and based in Piscataway, New Jersey.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full InnoPharma company profile →
Corridor Pharmaceuticals
HQ: United States
Website
- Description: Provider of platform-based pulmonary and critical care therapeutics, developing and commercializing small-molecule inhibitors of arginase to address elevated arginase levels, targeting arginase—an enzyme that competes with endothelial nitric oxide synthase for l-arginine and leads to ornithine production.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Corridor Pharmaceuticals company profile →
Valeo Pharma
HQ: Canada
Website
- Description: Provider of specialty pharmaceutical products and healthcare solutions, focused on commercializing innovative prescription therapies that address the needs of patients with complicated or rare diseases, serving healthcare professionals and patients.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Valeo Pharma company profile →
Antibe Therapeutics
HQ: Canada
Website
- Description: Provider of novel anti-inflammatory drugs that improve existing, proven therapies, targeting diseases characterized by inflammation, pain, and vascular dysfunction. Offers a proprietary hydrogen sulfide platform; pipeline includes Otenaproxesul for acute pain with demonstrated gastrointestinal safety and efficacy in chronic pain, ATB-352 for specialized pain, and a program for mild-to-moderate inflammatory bowel disease.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Antibe Therapeutics company profile →
HRA Pharma
HQ: France
Website
- Description: Provider of drugs, devices, and services in reproductive health and endocrine diseases, offering products such as Norlevo for emergency contraception; Cicatridine for vaginitis and vaginal injury; Delidose, Divina, and Duova for hormone replacement therapy; and GyMiso for cervical ripening.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full HRA Pharma company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Abbott
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Abbott
2.2 - Growth funds investing in similar companies to Abbott
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Abbott
4.2 - Public trading comparable groups for Abbott
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →